Literature DB >> 29883694

Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model.

Anjali Sharma1, Joshua E Porterfield2, Elizabeth Smith3, Rishi Sharma1, Sujatha Kannan4, Rangaramanujam M Kannan5.   

Abstract

Neurotherapeutics for the treatment of central nervous system (CNS) disorders must overcome challenges relating to the blood-brain barrier (BBB), brain tissue penetration, and the targeting of specific cells. Neuroinflammation mediated by activated microglia is a major hallmark of several neurological disorders, making these cells a desirable therapeutic target. Building on the promise of hydroxyl-terminated generation four polyamidoamine (PAMAM) dendrimers (D4-OH) for penetrating the injured BBB and targeting activated glia, we explored if conjugation of targeting ligands would enhance and modify brain and organ uptake. Since mannose receptors [cluster of differentiation (CD) 206] are typically over-expressed on injured microglia, we conjugated mannose to the surface of multifunctional D4-OH using highly efficient, atom-economical, and orthogonal Cu(I)-catalyzed alkyne-azide cycloaddition (CuAAC) click chemistry and evaluated the effect of mannose conjugation on the specific cell uptake of targeted and non-targeted dendrimers both in vitro and in vivo. In vitro results indicate that the conjugation of mannose as a targeting ligand significantly changes the mechanism of dendrimer internalization, giving mannosylated dendrimer a preference for mannose receptor-mediated endocytosis as opposed to non-specific fluid phase endocytosis. We further investigated the brain uptake and biodistribution of targeted and non-targeted fluorescently labeled dendrimers in a maternal intrauterine inflammation-induced cerebral palsy (CP) rabbit model using quantification methods based on fluorescence spectroscopy and confocal microscopy. We found that the conjugation of mannose modified the distribution of D4-OH throughout the body in this neonatal rabbit CP model without lowering the amount of dendrimer delivered to injured glia in the brain, even though significantly higher glial uptake was not observed in this model. Mannose conjugation to the dendrimer modifies the dendrimer's interaction with cells, but does not minimize its inherent inflammation-targeting abilities.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Activated glia; CD206; Cerebral palsy; Dendrimer; Mannose receptors; Nanoparticle; Neuroinflammation; Targeting

Mesh:

Substances:

Year:  2018        PMID: 29883694      PMCID: PMC6091673          DOI: 10.1016/j.jconrel.2018.06.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  64 in total

1.  Mannose functionalization of a sixth generation dendrimer.

Authors:  E K Woller; M J Cloninger
Journal:  Biomacromolecules       Date:  2001       Impact factor: 6.988

Review 2.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 3.  Transport of drugs across the blood-brain barrier by nanoparticles.

Authors:  Stefanie Wohlfart; Svetlana Gelperina; Jörg Kreuter
Journal:  J Control Release       Date:  2011-08-18       Impact factor: 9.776

4.  Mannosylation Allows for Synergic (CD44/C-Type Lectin) Uptake of Hyaluronic Acid Nanoparticles in Dendritic Cells, but Only upon Correct Ligand Presentation.

Authors:  Arianna Gennari; Maria Pelliccia; Roberto Donno; Ian Kimber; Nicola Tirelli
Journal:  Adv Healthc Mater       Date:  2016-02-10       Impact factor: 9.933

5.  Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.

Authors:  D A Tomalia; L A Reyna; S Svenson
Journal:  Biochem Soc Trans       Date:  2007-02       Impact factor: 5.407

6.  3H dendrimer nanoparticle organ/tumor distribution.

Authors:  Shraddha S Nigavekar; Lok Yun Sung; Mikel Llanes; Areej El-Jawahri; Theodore S Lawrence; Christopher W Becker; Lajos Balogh; Mohamed K Khan
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

7.  Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers.

Authors:  Chie Kojima; Celeste Regino; Yasuhito Umeda; Hisataka Kobayashi; Kenji Kono
Journal:  Int J Pharm       Date:  2009-09-15       Impact factor: 5.875

8.  Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.

Authors:  Elizabeth Nance; Fan Zhang; Manoj K Mishra; Zhi Zhang; Siva P Kambhampati; Rangaramanujam M Kannan; Sujatha Kannan
Journal:  Biomaterials       Date:  2016-05-26       Impact factor: 12.479

9.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

10.  Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET.

Authors:  Sujatha Kannan; Fadoua Saadani-Makki; Otto Muzik; Pulak Chakraborty; Thomas J Mangner; James Janisse; Roberto Romero; Diane C Chugani
Journal:  J Nucl Med       Date:  2007-05-15       Impact factor: 10.057

View more
  25 in total

Review 1.  Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

Authors:  Elizabeth S Smith; Joshua E Porterfield; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2019-03-04       Impact factor: 15.470

Review 2.  Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders.

Authors:  Abdul Waris; Asmat Ali; Atta Ullah Khan; Muhammad Asim; Doaa Zamel; Kinza Fatima; Abdur Raziq; Muhammad Ajmal Khan; Nazia Akbar; Abdul Baset; Mohammed A S Abourehab
Journal:  Nanomaterials (Basel)       Date:  2022-06-22       Impact factor: 5.719

Review 3.  Pharmacokinetics of nanotechnology-based formulations in pediatric populations.

Authors:  Venkata K Yellepeddi; Andrea Joseph; Elizabeth Nance
Journal:  Adv Drug Deliv Rev       Date:  2019-09-05       Impact factor: 15.470

4.  Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer-Conjugated TSPO Ligand that Stimulates Antitumor Signaling in Glioblastoma.

Authors:  Anjali Sharma; Kevin Liaw; Rishi Sharma; Ajit G Thomas; Barbara S Slusher; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Biomacromolecules       Date:  2020-08-31       Impact factor: 6.988

Review 5.  Embracing nanomaterials' interactions with the innate immune system.

Authors:  Abraham J P Teunissen; Marianne E Burnett; Geoffrey Prévot; Emma D Klein; Daniel Bivona; Willem J M Mulder
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-04-13

Review 6.  Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.

Authors:  Weisen Zhang; Ami Mehta; Ziqiu Tong; Lars Esser; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2021-03-07       Impact factor: 16.806

7.  Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma.

Authors:  Kevin Liaw; Rishi Sharma; Anjali Sharma; Sebastian Salazar; Santiago Appiani La Rosa; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2020-12-05       Impact factor: 9.776

Review 8.  Next generation strategies for preventing preterm birth.

Authors:  Hannah C Zierden; Rachel L Shapiro; Kevin DeLong; Davell M Carter; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2021-04-23       Impact factor: 17.873

9.  Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury.

Authors:  O Arteaga Cabeza; Z Zhang; E Smith Khoury; R A Sheldon; A Sharma; F Zhang; B S Slusher; R M Kannan; S Kannan; D M Ferriero
Journal:  Neurobiol Dis       Date:  2020-11-30       Impact factor: 5.996

10.  Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma.

Authors:  Rishi Sharma; Kevin Liaw; Anjali Sharma; Ambar Jimenez; Michelle Chang; Sebastian Salazar; Imaan Amlani; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2021-07-16       Impact factor: 11.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.